Related Experiment Video
Updated: Aug 29, 2026
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Feasibility of amifostine administration in conjunction with high-dose rate brachytherapy
1Texas Oncology PA, South Austin Cancer Center, 78745, USA.
Seminars in Oncology
|January 17, 2004
Abstract:
This ongoing study was initiated to determine the feasibility of administering amifostine (Ethyol, WR-2721; MedImmune, Inc, Gaithersburg, MD) with monomodal high-dose rate (mHDR) brachytherapy and to assess the tolerability and side effects of this combination. To date, 18 patients suitable for prostate implant brachytherapy (
